Calmettes C - Search Results

1

Effects of short-term subcutaneous administration of SMS 201-995 on calcitonin plasma levels in patients suffering from medullary thyroid carcinoma.

Guliana JM, Guillausseau PJ, Caron J, Siame-Mourot C, Calmettes C, Modigliani E. Guliana JM, et al. Among authors: calmettes c. Horm Metab Res. 1989 Oct;21(10):584-6. doi: 10.1055/s-2007-1009294. Horm Metab Res. 1989. PMID: 2807148 No abstract available.

2

[Detection and prognosis of medullary cancer of the thyroid gland. Influence of national multidisciplinary cooperation].

Guliana JM, Modigliani E, Guillausseau PJ, Aubert P, Milhaud G, Moukhtar MS, Calmettes C. Guliana JM, et al. Among authors: calmettes c. Presse Med. 1989 Mar 11;18(10):521-4. Presse Med. 1989. PMID: 2523043 French.

3

Heterogeneity of circulating calcitonin levels: relations with calcitonin biosynthesis in medullary thyroid carcinomas.

Guliana JM, Taboulet J, Calmettes C, Milhaud G, Moukhtar MS, Jullienne A. Guliana JM, et al. Among authors: calmettes c. Nucl Med Biol. 1994 Apr;21(3):359-68. doi: 10.1016/0969-8051(94)90059-0. Nucl Med Biol. 1994. PMID: 9234301 Review.

4

CCP II: a novel calcitonin carboxy terminal peptide is expressed in normal thyroid tissue.

Cohen R, Delehaye MC, Minvielle S, Segond N, Taboulet J, Noel M, Guliana JM, Calmettes C, Milhaud G, Lasmoles F. Cohen R, et al. Among authors: calmettes c. Biochem Biophys Res Commun. 1992 May 29;185(1):330-4. Biochem Biophys Res Commun. 1992. PMID: 1599469

5

The intratumoral immunoassayable somatostatin concentration is frequently elevated in medullary thyroid carcinoma. Results in 34 cases.

Modigliani E, Alamowitch C, Cohen R, Calmettes C, Guliana JM, Franc B, Bernard C, Chayvialle JA. Modigliani E, et al. Among authors: calmettes c. Cancer. 1990 Jan 15;65(2):224-8. doi: 10.1002/1097-0142(19900115)65:2<224::aid-cncr2820650208>3.0.co;2-y. Cancer. 1990. PMID: 1967221

6

Immunoreactive gastrin-releasing peptide in medullary thyroid carcinoma.

Modigliani E, Casanova S, Chayvialle JA, Bernard C, Franc B, Cohen R, Calmettes C. Modigliani E, et al. Among authors: calmettes c. J Clin Endocrinol Metab. 1990 Oct;71(4):831-5. doi: 10.1210/jcem-71-4-831. J Clin Endocrinol Metab. 1990. PMID: 1976126

7

PCR amplification of CGRP II mRNA. Variable expression in tumoral and non-tumoral human thyroid.

Lasmoles F, Minvielle S, Cohen R, Guliana JM, Delehaye MC, Segond N, Calmettes C, Milhaud G, Moukhtar MS. Lasmoles F, et al. Among authors: calmettes c. FEBS Lett. 1990 Dec 17;277(1-2):243-6. doi: 10.1016/0014-5793(90)80856-e. FEBS Lett. 1990. PMID: 2269360 Free article.

8

[Multiple endocrine neoplasms type 2. Recent aspects].

Guillausseau PJ, Calmettes C, Feingold N, Franc B, Guillausseau-Scholer C, Modigliani E, Sobol H. Guillausseau PJ, et al. Among authors: calmettes c. Presse Med. 1991 Dec 21-28;20(44):2256-62. Presse Med. 1991. PMID: 1685777 Review. French.

9

Plasma and tumor levels of somatostatin (SRIF) and somatostatin immunochemistry in medullary thyroid carcinoma: apparently discrepant preliminary results.

Franc B, Chayvialle JA, Modigliani E, Calmettes C, Caillou B, Dutrieux-Berger N, Houdent C, Kujas M. Franc B, et al. Among authors: calmettes c. Henry Ford Hosp Med J. 1987;35(2-3):147-8. Henry Ford Hosp Med J. 1987. PMID: 2891647 Free article. No abstract available.

10

[Endocrine polyadenomatosis of 2a type (MEN 2a). Clinical and genetic study of a family].

Guillausseau PJ, Guillausseau C, Calmettes C, Feingold N, Demenais F, Sobol H, Gony J, Hors J, Schaison G, Seret D, et al. Guillausseau PJ, et al. Among authors: calmettes c. Ann Endocrinol (Paris). 1988;49(1):17-21. Ann Endocrinol (Paris). 1988. PMID: 2900619 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters